Search research articles
Contact Us
Filters
Showing results (281-290 of 309) with videos related to
Page
of 31
Sort By:
Breast Cancer Research and Treatment
|
October 23, 2021
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer
Pauline Corbaux, Audrey Lardy-Cleaud, Marie Alexandre, et al.
Diagnostic and Interventional Imaging
|
May 13, 2025
The continued industrial use of ethylene oxide despite health risks: An interventional radiology perspective on a broader medical challenge of balancing sterility, safety, and sustainability
Julien Ognard, Marie Schmidt, Christophe Paya, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 20, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001
Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, et al.
Eclinicalmedicine
|
November 18, 2020
Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study
Bruno Coudert, Jean-Yves Pierga, Marie-Ange Mouret-Reynier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2019
UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2-positive subgroup
Véronique D'Hondt, Jean-Luc Canon, Lise Roca, et al.
Neuroimage
|
February 7, 2021
Association of quality of life with structural, functional and molecular brain imaging in community-dwelling older adults
Valentin Ourry, Julie Gonneaud, Brigitte Landeau, et al.
The Oncologist
|
August 17, 2023
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program
Fanny Le Du, Matthieu Carton, Thomas Bachelot, et al.
EMBO Molecular Medicine
|
March 24, 2018
Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis
Marianna Parlato, Fabienne Charbit-Henrion, Jie Pan, et al.
Molecular Cell
|
January 18, 2016
TRF2-Mediated Control of Telomere DNA Topology as a Mechanism for Chromosome-End Protection
Delphine Benarroch-Popivker, Sabrina Pisano, Aaron Mendez-Bermudez, et al.
Cell Chemical Biology
|
September 24, 2019
Design on a Rational Basis of High-Affinity Peptides Inhibiting the Histone Chaperone ASF1
May Bakail, Albane Gaubert, Jessica Andreani, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 309) with videos related to
Sort By:
Page
of 31
Breast Cancer Research and Treatment
|
October 23, 2021
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer
Pauline Corbaux, Audrey Lardy-Cleaud, Marie Alexandre, et al.
Diagnostic and Interventional Imaging
|
May 13, 2025
The continued industrial use of ethylene oxide despite health risks: An interventional radiology perspective on a broader medical challenge of balancing sterility, safety, and sustainability
Julien Ognard, Marie Schmidt, Christophe Paya, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 20, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001
Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, et al.
Eclinicalmedicine
|
November 18, 2020
Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study
Bruno Coudert, Jean-Yves Pierga, Marie-Ange Mouret-Reynier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2019
UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2-positive subgroup
Véronique D'Hondt, Jean-Luc Canon, Lise Roca, et al.
Neuroimage
|
February 7, 2021
Association of quality of life with structural, functional and molecular brain imaging in community-dwelling older adults
Valentin Ourry, Julie Gonneaud, Brigitte Landeau, et al.
The Oncologist
|
August 17, 2023
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program
Fanny Le Du, Matthieu Carton, Thomas Bachelot, et al.
EMBO Molecular Medicine
|
March 24, 2018
Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis
Marianna Parlato, Fabienne Charbit-Henrion, Jie Pan, et al.
Molecular Cell
|
January 18, 2016
TRF2-Mediated Control of Telomere DNA Topology as a Mechanism for Chromosome-End Protection
Delphine Benarroch-Popivker, Sabrina Pisano, Aaron Mendez-Bermudez, et al.
Cell Chemical Biology
|
September 24, 2019
Design on a Rational Basis of High-Affinity Peptides Inhibiting the Histone Chaperone ASF1
May Bakail, Albane Gaubert, Jessica Andreani, et al.
Page
of 31